HealthTree Logo HealthTree Foundation
Donate

Notifications

You're all caught up

HealthTree Logo
Donate
Personal Health Record
  • My Feed
  • Recently viewed

Learn

  • Topics
  • Events

Explore

  • Find treatments & trials
  • Participate in research
  • Find a coach
  • Find a specialist
  • Talk to a patient navigator
  • Get involved
  • For researchers
  • For healthcare providers
  • About us
  • Get involved
  • For researchers
  • For healthcare providers
  • About us

Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Learn more about HealthTree
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Video

Can Iberdomide Replace Revlimid in Newly Diagnosed Myeloma? KId Results | IMS 2026

Posted by
HealthTree Logo HealthTree
• October 9, 2026

Related Content

  • Video Iberdomide + Daratumumab More Than Doubles MRD-Negative Rates in Myeloma -EXCALIBER | IMS 2026
  • Video Does Tec-Dara Help Myeloma Patients Live Longer? | IMS 2026
  • Video Iberdomide Plus Dara After Transplant: Early Safety and Results | IMS 2026
  • Video A New CELMoD Contender: SUCCESSOR-2 Highlights Mezigdomide’s Potential in Myeloma | EHA 2026
  • Video The CELMoD, Mezigdomide, Shows Dramatic Results in Relapsed Myeloma | Paul Richardson, MD | #IMS25
  • Video All-Oral Myeloma Combo: Mezigdomide + Tazemetostat or Trametinib | Paul Richardson, MD | EHA 2025